News
- Press Releases
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
- In the news
Norstella’s AI bet: Clinical trials are often won or lost before the first patient enrolls
Somewhere in the world right now, a patient sits in a clinic waiting room ahead of a clinical trial visit. On the clipboard is eligibility status, recent labs, comorbidities, medication history, prior notes, all of it needing clinician review before anything else happens. This is…
- Press Releases
Recursion expands strategic partnership with Citeline to advance its AI-enabled ClinTech platform
- Press Releases
Fred Hassan appointed Executive Chair of Norstella
- Press Releases
Norstella appoints Dan Tempesta as Chief Financial Officer
Insights
- Article
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes
T1D Exchange published research in Diabetes Technology & Therapeutics using NorstellaLinQ lab data linked to their T1D patient registry and wearable device data. The objective of the study was to evaluate the prevalence of cardiovascular, renal, and hepatic biomarkers that fall outside guideline-based thresholds in…
- Article
Why an AI-native biotech chose Norstella
Drug development has made huge scientific progress over the last decade. The way we run clinical development has changed far less. Timelines are still long. Costs are still high. And most of the risk is decided before a trial even begins—we just don’t treat it…
- Article
Wall Street Journal spotlights Norstella in post-pandemic vaccines feature
Norstella recently spoke with the Wall Street Journal’s Brian Gormley in a feature article: Biotech VC’s Vaccine Die-Hards. The piece explores how investment has pivoted away from vaccines, leaving a select group of committed developers to carry the flag. Strides made during the pandemic mean…
- Article
Rare … but actually not that rare
Rare Disease Day will be commemorated on 28 February this year, as it has been every year since 2008. Coordinated by EURORDIS-Rare Diseases Europe, the day will bring together over 70 national groups across 106 countries in over 600 events to raise awareness and drive…
- Article
Early oral GLP-1 uptake is half the story: Who is initiating reveals a bigger shift
In the first few weeks following the launch of oral semaglutide, early prescription activity answered a familiar question: Uptake was occurring and growing exponentially within a matter of weeks. But a more consequential signal emerged when looking beyond prescription counts to the patients themselves. After…
Events
- Conference
- August 2026
Ai4
- Conference
- August 2026
ISPE
- Conference
- September 2026
Fierce Pharma Week
- Conference
- October 2026
AMCP Nexus
- Conference
- November 2026
ISPOR EU
Work with us
Join Our Mission
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Get in touch
Let's Connect
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?
The Full Picture of
Drug Development Description
Follow Norstella to clear the hurdles from pipeline to patient.
